BRYSON VAUGHN D 4
4 · AMYLIN PHARMACEUTICALS INC · Filed Jan 3, 2005
Insider Transaction Report
Form 4
BRYSON VAUGHN D
Director
Transactions
- Award
Phantom Stock-Deferred Compensation
2004-12-30$23.47/sh+415$9,740→ 2,960 total→ Common Stock (415 underlying)
Footnotes (2)
- [F1]Conversion or Exercise Price of Derivative security is 1-for-1.
- [F2]The shares of phantom stock become payable, at the election of the reporting person, upon the earliest to occur of the reporting persons termination of service as a director, the date on which the reporting person reaches 72 years of age, or upon a change in control of the issuer.